Q32 Bio

Forecast & Rating5 analysts currently cover Q32 Bio, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $38.75, about 154.8% upside from the current price of $15.21. Price targets range from $13.00 to $66.00 — a wide spread, showing clear disagreement over just how much Q32 Bio can rise. Historically, about 26.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Q32 Bio closely still see room for the stock to rise. Data as of Jul 14, 2026; for reference only and not investment advice.